Feature
Innovent Announces Gastric Cancer Trial Win for Tyvyt, Reveals Plans for Another China Approval
2021-08-16
With Increasing Appeal for RNA Technology, Medford Startup Jumps on the SPAC Wagon to Go Public
2021-08-10
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03